Assessing and Treating Clients With Psychosis and Schizophrenia Case Study
Description
please complete the interactive case study below and explain choices made at each decision checkpoint
https://mym.cdn.laureate-media.com/2dett4d/Walden/…
Examine Case Study: Pakistani Woman with Delusional Thought Processes.You will be asked to make three decisions concerning the medication toprescribe to this client. Be sure to consider factors that might impactthe client’s pharmacokinetic and pharmacodynamic processes.
At each decision point stop to complete the following:
- Decision #1
- Which decision did you select?
- Why did you select this decision? Support your response with evidence and references to the Learning Resources.
- What were you hoping to achieve by making this decision? Supportyour response with evidence and references to the Learning Resources.
- Explain any difference between what you expected to achieve withDecision #1 and the results of the decision. Why were they different?
- Decision #2
- Why did you select this decision? Support your response with evidence and references to the Learning Resources.
- What were you hoping to achieve by making this decision? Supportyour response with evidence and references to the Learning Resources.
- Explain any difference between what you expected to achieve withDecision #2 and the results of the decision. Why were they different?
- Decision #3
- Why did you select this decision? Support your response with evidence and references to the Learning Resources.
- What were you hoping to achieve by making this decision? Supportyour response with evidence and references to the Learning Resources.
- Explain any difference between what you expected to achieve withDecision #3 and the results of the decision. Why were they different?
Also include how ethical considerations might impact your treatment plan and communication with clients.
please include at least 5 scholarly journal articles and at least one from the following list:
Stanley R. Kay, Abraham Fiszbein, Lewis A. Opler, The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia, Schizophrenia Bulletin, Volume 13, Issue 2, 1987, Pages 261–276,
Naber, D., & Lambert, M. (2009). The CATIE and CUtLASS studies in schizophrenia: results and implications for clinicians. CNS Drugs, 23(8), 649–659.
Stahl, S. M. (2013). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). New York, NY: Cambridge University Press.
